Banner

HISA Event on Technology and Human Disease

Last update on July 19, 2016.


This HISA event provides an overview of the necessary ingredients for the successful deployment of an eHealth solution.

Health Informatics Society Australia (HISA) represents Australia's diverse and multi-disciplinary digital healthcare community. Every year HISA hosts a range of quality events on both state and national level, tailored to meet the needs and interests of their members. On August 25th Professor Matthew Bellgard with be holding a HISA event in Perth.


HISA Event on Technology and Human Disease
Speakers: Professor Matthew Bellgard, Dr Jing Pang & Jacqueline Ryan
When: Thursday 25 th August 2016 at 5:30pm – 7:00pm
Where: CSC, Level 1, 516 Hay Street, Subiaco


Title: The imperative to address better management of human disease through eHealth and Data Science: A case study demonstrating a successful international patient registry for Familial Hypercholesterolemia


Familial Hypercholesterolaemia (FH) is the most common and serious monogenic disorder of lipoprotein metabolism that leads to premature coronary heart disease. Over 65,000 people estimated to have FH in Australia, yet many remain undiagnosed. Patients with FH are often under-treated, yet with early detection, cascade family testing and adequate treatment, patient outcomes can be improved.


The purpose of the Familial Hypercholesterolaemia Registry is to collate data to facilitate clinical service planning and to inform clinical best practice. The Registry will also enable research on aggregated data and the identification of eligible volunteers for clinical trials.


This HISA presentation provides an overview of the necessary ingredients for the successful deployment of an eHealth solution for improved management of human disease. This solution serves as a model for other human chronic and rare conditions and its role within the eHealth ecosystem is discussed.


Registration Fees


This event is free for HISA member and $25.00 for non-members. Please register via the bellow link to confirm your attendance. 
For registration please visit HISA website.


About Speakers


Professor Matthew Bellgard Professor and Foundation Chair of Bioinformatics, Director, Centre for Comparative Genomics, Murdoch University

Professor Bellgard is the inaugural Director of the Centre for Comparative Genomics (CCG) and the Professor and Foundation Chair of Bioinformatics, based at Murdoch University. The CCG, a Western Australian State Government Centre for Excellence, undertakes research in the biomedical and agricultural sciences on themes as diverse as human health, personalised medicine, food security, environmental management, animal and plant genomics and pathogens and viruses. As CCG Director, he was responsible for the expansion of the Centre into the field of molecular therapy, pioneering research on new therapies for muscular dystrophy. Under his leadership, he led the Centre into exponential growth. Professor Bellgard is a computer scientist with a PhD from the University of Western Australia in the field of artificial intelligence. He has a particular interest in rare diseases research and is the co-leader of the Australian RD Connect consortium, FP7 €12 million project, which provides an integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease. He is Project Director for the design and deployment of e-health solutions such as international patient registries and a biobank e-health system in a Western Australian hospital. He will also be coordinating the Health Informatics Unit as part of Murdoch University’s new Master of Health Policy and Leadership. His scientific work has resulted in developments in both the areas of pairwise sequence alignment and artificial intelligence, bacterial bioinformatics, whole genome analysis and annotation for a range of species, as well as Big data and eResearch within a range of disciplines.


Dr Jing Pang National Coordinator, Familial Hypercholesterolaemia Registry 10-Countries Study, University of Western Australia

Dr Jing Pang is a prominent researcher in the field of Familial Hypercholesterolaemia (FH). Currently she is the National Coordinator of ‘Familial Hypercholesterolaemia Registry’ & overall coordinator of the ‘10-Countries Study’ at the University of Western Australia. Dr Jing Pang completed her undergraduate studies at the University of Sydney and her PhD in Medicine at the School of Medicine and Pharmacology, University of Western Australia. Her research interest centered around the challenges posed by FH - its detection, management and treatment. She has contributed significantly to the development of the FH Australasia Registry and is currently the national coordinator of the project. She is also the coordinator of the translational research project on FH that spans across 10 countries in the Asia-Pacific region (the “10 Countries Study”). As a prolific researcher, she has contributed to 33 peer reviewed publications, which include scientific articles, reviews and book chapters, of which 20 are specific to FH. Dr Jing partakes in educational and health service activities for the FH Western Australia (FHWA) program, which enhance integration among specialist departments and collaborations with primary care, health economists and international collaborators. The program won the Western Australian Health Excellence Award in 2014 for its work in primary care. Dr Jing is also involved in initiatives with the FH Family Support Group and the FH Australasia Network.


Jacqueline Ryan Clinical Research Coordinator, University of Western Australia

Jackie is an Endorsed Nurse Practitioner in Cardiometabolic Disorders, Assessment and Diagnosis. Her General Nursing training was hospital based at Nepean Hospital in Sydney. Jackie has a Post Graduate diploma in Coronary Care, obtained at the New South Wales College of Nursing, following with a Post Graduate Diploma in Health Sciences from Curtin University, Master of Nursing Thesis and Course work from Edith Cowan and a Master of Nursing (Nurse Practitioner) from Flinders University and Edith Cowan University. Jackie initially worked as a Primary Care FH Liaison Nurse Practitioner at the School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, where she was able to provide clinical liaison and education to Primary Care providers to raise awareness of Familial Hypercholesterolaemia (FH) in the community. Jackie partook in educational and health service activities for the FH Western Australia (FHWA) program, which enhanced integration among specialist departments and collaborations with primary care, health economists and international collaborators. The program won the Western Australian Health Excellence Award in 2014 for its work in primary care. In 2014 Jackie, having been granted a designation of Cardiometabolic Disorders Assessment and Diagnostic Services by the Health Department of WA, Jackie initiated Lipid Disorders Clinics in three GP practices in the primary care setting where she manages individuals and their families with FH. These clinics enhance detection, screening and management and of this genetic disorder in primary care. Early detection and management prevents early onset cardiovascular disease (CVD). This initiative requires advanced knowledge, assessment and diagnostic interpretative skills. Jackie has a primary care node for the FH Registry.


LATEST PUBLICATIONS See all
  • 24 July 2015

    The emperor's new dystrophin: finding sense in the noise

    READ MORE

  • 24 July 2015

    Editorial: medicinal chemistry of aptamers

    READ MORE